Cell & Gene Therapy Raw Material Testing Market Size & Trends

Cell & Gene Therapy Raw Material Testing Market Size & Trends

According to a new market research report published by Global Market Estimates, the Global Cell & Gene Therapy Raw Material Testing Market is projected to grow from USD 13.1 billion in 2022 to USD 21.3 billion in 2027 at a CAGR of 17.3% from 2022 to 2027.

Thermo Fisher Scientific, Merck KGaA, Catalent Inc., Charles River, Pace Analytical Life Sciences, Agilent Technologies, Intertek Group PLC, Element Material Technology, and Eurofins Scientific, among others, are some key players in the cell & gene therapy raw material testing market.

Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and indepth TOC on “Global Cell & Gene Therapy Raw Material Testing Market - Forecast to 2027’’ https://www.globalmarketestimates.com/market-report/cell-gene-therapy-rawmaterial-testing-market-3867

By Type Scope (Cell Therapy, Gene Therapy), By Service Scope (Sterility Testing, Mycoplasma Detection Assays, Endotoxin Detection, Bioburden Testing, Others), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

Service Scope Outlook (Revenue, USD Billion, 2022-2027)     

Sterility Testing Mycoplasma Detection Assays Endotoxin Detection Bioburden Testing Others

Type Scope Outlook (Revenue, USD Billion, 2022-2027)  

Cell Therapy Gene Therapy

Regional Outlook (Revenue, USD Billion, 2022-2027) North America   

The U.S. Canada Mexico

Europe      

Germany UK France Spain Italy Rest of Europe

Asia Pacific      

China India Japan South Korea Australia Rest of APAC

Central & South America   

Brazil Argentina Rest of CSA

Middle East & Africa   

Saudi Arabia UAE Rest of MEA

Contact: Yash Jain Email address: yash.jain@globalmarketestimates.com Phone Number: +1 6026667238